| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
124,070,000 |
| Market
Cap: |
137.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.5599 - $6.19 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seres Therapeutics is a microbiome therapeutics platform company developing live biotherapeutic drugs. SER-109, Co.'s lead clinical candidate is an oral, purified bacterial spore-based microbiome therapeutic candidate consisting of a consortium of purified Firmicutes spores. Using Co.'s microbiome therapeutics platform, Co. is also developing SER-287 and SER-301 to treat ulcerative colitis. Co. evaluates microbiome pharmacokinetic and pharmacodynamic data from across its clinical and pre-clinical portfolios using its reverse translation microbiome therapeutics capabilities to conduct research on various indications, including inflammatory and immune diseases, cancer, and metabolic diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
8,738,243 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,525,465 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
36,381 |
36,381 |
71,150 |
83,200 |
| Total Sell Value |
$39,292 |
$39,292 |
$86,229 |
$162,501 |
| Total People Sold |
7 |
7 |
8 |
8 |
| Total Sell Transactions |
7 |
7 |
15 |
17 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Aunins John G. |
Chief Technology Officer & EVP |
• – – |
2016-05-31 |
4 |
AS |
$30.02 |
$421,088 |
D/D |
(14,015) |
42,045 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-05-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,033,514) |
0 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-05-25 |
4 |
A |
$0.00 |
$0 |
I/I |
33,514 |
33,514 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-05-25 |
4 |
S |
$27.60 |
$27,600,000 |
I/I |
(1,000,000) |
0 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-24 |
4 |
AS |
$30.00 |
$294,030 |
D/D |
(9,801) |
183,692 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-24 |
4 |
OE |
$0.71 |
$6,959 |
D/D |
9,801 |
193,493 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-18 |
4 |
OE |
$0.71 |
$114,285 |
D/D |
160,965 |
183,692 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-06 |
4 |
AS |
$24.28 |
$206,803 |
D/D |
(8,507) |
22,727 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-06 |
4 |
OE |
$0.71 |
$6,040 |
D/D |
8,507 |
31,234 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-05 |
4 |
AS |
$25.48 |
$772,742 |
D/D |
(30,027) |
22,727 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-05 |
4 |
OE |
$0.71 |
$21,319 |
D/D |
30,027 |
31,627 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-04 |
4 |
AS |
$26.52 |
$777,536 |
D/D |
(29,298) |
22,727 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-04 |
4 |
OE |
$0.71 |
$20,802 |
D/D |
29,298 |
23,427 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-03 |
4 |
AS |
$27.80 |
$663,179 |
D/D |
(23,680) |
22,727 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-03 |
4 |
OE |
$0.71 |
$16,813 |
D/D |
23,680 |
46,407 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-02 |
4 |
AS |
$28.95 |
$1,270,018 |
D/D |
(43,687) |
22,727 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-05-02 |
4 |
OE |
$0.71 |
$31,018 |
D/D |
43,687 |
66,414 |
|
- |
|
| Aunins John G. |
Chief Technology Officer & EVP |
• – – |
2016-04-25 |
4 |
AS |
$31.94 |
$595,362 |
D/D |
(18,640) |
56,060 |
|
- |
|
| Cook David N |
Chief Scientific Officer & EVP |
• – – |
2016-04-07 |
4 |
AS |
$31.00 |
$248,000 |
D/D |
(8,000) |
160,673 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-04-07 |
4 |
AS |
$30.00 |
$276,360 |
D/D |
(9,212) |
22,727 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-04-07 |
4 |
OE |
$0.48 |
$6,147 |
D/D |
9,212 |
31,939 |
|
- |
|
| Shaff Eric D. |
CFO and EVP |
• – – |
2016-04-04 |
4 |
AS |
$28.85 |
$189,487 |
D/D |
(6,568) |
0 |
|
- |
|
| Shaff Eric D. |
CFO and EVP |
• – – |
2016-04-04 |
4 |
OE |
$7.79 |
$51,165 |
D/D |
6,568 |
6,568 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-04-04 |
4 |
AS |
$28.17 |
$1,296,493 |
D/D |
(44,825) |
22,727 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2016-04-04 |
4 |
OE |
$0.48 |
$21,516 |
D/D |
44,825 |
67,552 |
|
- |
|
195 Records found
|
|
Page 7 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.08 (6.72%) 
